Jump to content


Biomarker for Diffuse Scleroderma skin has been discovered!


Photo

Periodontitis treatment improves systemic lupus erythematosus response to immunosuppressive therapy.

SLE treatments immunosuppressants

  • Please log in to reply
No replies to this topic

#1 Joelf

Joelf

    Star Ruby Member

  • ISN Root Admin
  • PipPipPipPipPipPipPipPipPipPipPipPipPip
  • 4,610 posts
  • Location:West Sussex

Posted 23 March 2014 - 01:21 PM

Periodontitis treatment improves systemic lupus erythematosus response to immunosuppressive therapy.

 

Periodontal disease treatment seems to have a beneficial effect in controlling disease activity in SLE patients under immunosuppressive therapy and therefore, management of this modifiable risk factor is recommended. PubMed, Clin Rheumatol, 2014 Jan 11. (Also see: Systemic Lupus Erythematosus Treatments and Immunosuppressants)

 

This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.


Jo Frowde
ISN Assistant Webmaster

SD World Webmaster
ISN Sclero Forums Manager
ISN News Manager

ISN Hotline Support Specialist
ISN Chat Host
International Scleroderma Network (ISN)